Evidence map›Paper›PMID 32231177›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.

Zongbiao Tian, Zheng Wang, Yanfeng Chen, Shuoying Qu, Changhong Liu, Fengzhe Chen, Lixian Ma, Jie Zhu

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zongbiao TianDepartment of Gastroenterology, TengZhou Central People's Hospital, Tengzhou, Shandong, China (mainland).
Zheng WangDepartment of Infectious Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, China (mainland).
Yanfeng ChenDepartment of Gastroenterology, TengZhou Central People's Hospital, Tengzhou, Shandong, China (mainland).
Shuoying QuDepartment of Clinical Laboratory, Qilu Hospital, Shandong University, Jinan, Shandong, China (mainland).
Changhong LiuDepartment of Gastroenterology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, China (mainland).
Fengzhe ChenDepartment of Infectious Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, China (mainland).
Lixian MaDepartment of Infectious Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, China (mainland).
Jie ZhuDepartment of Infectious Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, China (mainland).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Growing evidence shows that the tumor microenvironment plays a crucial role in the pathogenesis of hepatocellular carcinoma (HCC). The present work aimed to screen tumor microenvironment-related genes strongly related to prognosis and to construct a prognostic gene expression model for HCC. MATERIAL AND METHODS We downloaded gene expression data of 371 HCC patients in The Cancer Genome Atlas (TCGA). A novel ESTIMATE algorithm was applied to calculate immune scores and stromal scores for each patient. Then, the differentially-expressed genes (DEGs) were detected according to the immune and stromal scores, and tumor microenvironment-related genes were further explored. Univariate, Lasso, and multivariate Cox analyses were performed to build the tumor microenvironment-related prediction model. RESULTS Stromal and immune scores were calculated and were found to be correlated with the 3-year prognosis of HCC patients. DEGs were detected according to the stromal and immune scores. There were 49 genes with prognostic value in both TCGA and ICGC (International Cancer Genome Consortium) considered as prognostic tumor microenvironment-related genes. Univariate, Lasso, and multivariate Cox analyses were conducted. A novel 2-gene signature (IL18RAP and GPR182) was built for HCC 3-year prognosis prediction. The 2-gene signature was regarded as an independent prognostic predictor that was correlated with 3-year survival rate, as shown by Cox regression analysis. CONCLUSIONS This study offers a novel 2-gene signature to predict overall survival of patients with HCC, which has the potential to be used as an independent prognostic predictor. Overall, this study reveals more details about the tumor microenvironment in HCC and offers novel candidate biomarkers.

Indexed as

AgedAlgorithmsBiomarkers, TumorCarcinoma, HepatocellularComputational BiologyDatasets as TopicFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansInterleukin-18 Receptor beta SubunitKaplan-Meier EstimateLiver NeoplasmsMaleMiddle AgedPrognosisBiomarkers, TumorGPR182 protein, humanIL18RAP protein, humanInterleukin-18 Receptor beta SubunitReceptors, G-Protein-Coupled

Identifiers

PMID32231177
PMCPMC7146066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.